Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicoletta Fortunati

Showing results (1-10 of 41) with videos related to

Pageof 5
Sort By:
Diabetes Research and Clinical Practice|February 24, 2018
Cancer survivors: An expanding population with an increased cardiometabolic riskFrancesco Felicetti, Nicoletta Fortunati, Enrico Brignardello
Frontiers in Endocrinology|June 1, 2012
Epigenetics modifications and therapeutic prospects in human thyroid cancerMaria Graziella Catalano, Nicoletta Fortunati, Giuseppe Boccuzzi
Frontiers of Hormone Research|March 1, 2017
Thyroid Autoimmunity and CancerFrancesco Felicetti, Maria Graziella Catalano, Nicoletta Fortunati
Best Practice & Research. Clinical Endocrinology & Metabolism|December 16, 2016
GH deficiency in adult survivors of childhood cancerFrancesco Felicetti, Nicoletta Fortunati, Emanuela Arvat, et al.
Frontiers of Hormone Research|May 4, 2021
Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health ManagementNicoletta Fortunati, Filippo Gatti, Francesco Felicetti, et al.
Molecular and Cellular Endocrinology|August 6, 2002
The androgen receptor CAG repeat: a modifier of carcinogenesis?Paola Ferro, Maria G Catalano, Raffaella Dell'Eva, et al.
Molecular Aspects of Medicine|February 24, 2010
Emerging molecular therapies of advanced thyroid cancerMaria Graziella Catalano, Roberta Poli, Mariateresa Pugliese, et al.
Endocrine-Related Cancer|October 5, 2007
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell linesMaria G Catalano, Roberta Poli, Mariateresa Pugliese, et al.
Breast Cancer Research and Treatment|October 9, 2003
High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cellsRoberto Frairia, Maria G Catalano, Nicoletta Fortunati, et al.
International Journal of Oncology|December 25, 2013
The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotypeNicoletta Fortunati, Francesca Marano, Andrea Bandino, et al.
Pageof 5

Showing results (1-10 of 41) with videos related to

Sort By:
Pageof 5
Diabetes Research and Clinical Practice|February 24, 2018
Cancer survivors: An expanding population with an increased cardiometabolic riskFrancesco Felicetti, Nicoletta Fortunati, Enrico Brignardello
Frontiers in Endocrinology|June 1, 2012
Epigenetics modifications and therapeutic prospects in human thyroid cancerMaria Graziella Catalano, Nicoletta Fortunati, Giuseppe Boccuzzi
Frontiers of Hormone Research|March 1, 2017
Thyroid Autoimmunity and CancerFrancesco Felicetti, Maria Graziella Catalano, Nicoletta Fortunati
Best Practice & Research. Clinical Endocrinology & Metabolism|December 16, 2016
GH deficiency in adult survivors of childhood cancerFrancesco Felicetti, Nicoletta Fortunati, Emanuela Arvat, et al.
Frontiers of Hormone Research|May 4, 2021
Cancer Treatment-Induced Bone Loss in Hormone-Sensitive Cancer: The Paradigm of Cancer Survivor Bone Health ManagementNicoletta Fortunati, Filippo Gatti, Francesco Felicetti, et al.
Molecular and Cellular Endocrinology|August 6, 2002
The androgen receptor CAG repeat: a modifier of carcinogenesis?Paola Ferro, Maria G Catalano, Raffaella Dell'Eva, et al.
Molecular Aspects of Medicine|February 24, 2010
Emerging molecular therapies of advanced thyroid cancerMaria Graziella Catalano, Roberta Poli, Mariateresa Pugliese, et al.
Endocrine-Related Cancer|October 5, 2007
Valproic acid enhances tubulin acetylation and apoptotic activity of paclitaxel on anaplastic thyroid cancer cell linesMaria G Catalano, Roberta Poli, Mariateresa Pugliese, et al.
Breast Cancer Research and Treatment|October 9, 2003
High energy shock waves (HESW) enhance paclitaxel cytotoxicity in MCF-7 cellsRoberto Frairia, Maria G Catalano, Nicoletta Fortunati, et al.
International Journal of Oncology|December 25, 2013
The pan-histone deacetylase inhibitor LBH589 (panobinostat) alters the invasive breast cancer cell phenotypeNicoletta Fortunati, Francesca Marano, Andrea Bandino, et al.
Pageof 5